Patients who start ART at baseline CD4 counts <200 cells/μl have frequently been demonstrated to have a poor immune recovery [25, 26] with increased risk of both AIDS and non-AIDS-related morbidities and mortalities [27, 28]. This evidence concerns the gene CD4 and AIDS.